NCM
MRNA icon

Northwest Capital Management’s Moderna MRNA Stock Holding History

Northwest Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$2.83K – 413
2025
Q1 		$2.83K Hold
100
– – ﹤0.01% 381
2024
Q4 		$4.16K Hold
100
– – ﹤0.01% 351
2024
Q3 		$6.68K Hold
100
– – ﹤0.01% 347
2024
Q2 		$11.9K Hold
100
– – ﹤0.01% 308
2024
Q1 		$10.7K Hold
100
– – ﹤0.01% 383
2023
Q4 		$9.95K Hold
100
– – ﹤0.01% 377
2023
Q3 		$10.3K Hold
100
– – ﹤0.01% 359
2023
Q2 		$12.2K Buy
+100
New +$13.3K 0.01% 352

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northwest Capital Management's MRNA Position: Q2 2025 in Review

Northwest Capital Management sold out of Moderna (MRNA) in Q2 2025, closing a stake of 100 shares — an estimated $2.83K sold.

Northwest Capital Management first reported a position in MRNA in Q2 2023 and held it in 8 quarters. The position peaked at $12.2K in Q2 2023. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Northwest Capital Management reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Northwest Capital Management sold 100 Moderna shares in Q2 2025, an estimated $2.83K.
  • Northwest Capital Management first reported a position in Moderna in Q2 2023 and held it in 8 quarters.
  • Northwest Capital Management's Moderna position peaked at $12.2K in Q2 2023.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Northwest Capital Management's 13F filing for Q2 2025, filed 25 Jul 2025.